It was the worst deal ( ALT-003) for investors I've ever seen in my time with biotechs and I did sell much of what I had in the teens. Just batting for whats left (options) and maybe some others who think the board/MD have responsiblibity with investors cash to develope a strategy to create VALUE.....
Plenty of risk investors know about (101) but its not carte blanche to perform poorly, give the company away and keep some information from market while they (board/MD) get remunirated year in year out!
15 years is long enough and someone needs to say it!
IMO!
ANP Price at posting:
6.6¢ Sentiment: None Disclosure: Held
